Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.50    0.50 (0.22%)
Bid:
228.00
Ask:
229.00
Spread: 1.00 (0.439%)
Market Cap: £631.61m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

17 Nov 2010 07:00

RNS Number : 3048W
Morgan Crucible Co PLC
17 November 2010
 



Press Release

Interim Management Statement

The Morgan Crucible Company plc

17th November 2010

 

 

The statement below constitutes Morgan Crucible's Interim Management Statement for the period from 4th July to 17th November 2010.

 

 

·; The Group has continued to see positive trading momentum over the period since it reported its half year results

 

·; Profits for the full year are now expected to be in the top half of analyst forecasts*

 

·; In the ten month period to October year-on-year revenue growth was c.7%. Excluding NP Aerospace and at constant currency, revenue growth over the same period was c.16%, compared to the c.10% reported at the half year

 

·; Good progress is being made to realise the benefits of the divisional streamlining that was announced at the interim results. Our expectation remains to deliver at least £5m of cost savings in 2011 rising to £6-8m in 2012

 

·; The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end, driven by good cash generation from the positive trading performance

 

 

* Analyst forecasts for 2010 EBITA (before restructuring) are between £98.8m and £109.0m.

 

 

 

Outlook

 

With the Group continuing to see good trading momentum across most of its end markets, our outlook remains positive. In addition our ongoing focus on higher margin niche end markets, coupled with continuing benefits from cost base reductions, leaves us well placed for further progress into 2011.

 

  

Morgan Ceramics Division

 

The Technical Ceramics and Thermal Ceramics businesses were merged in July 2010 and are now run under a single integrated leadership team which is making good progress to realise both cost synergies and revenue growth opportunities.

 

Technical Ceramics Business

 

The majority of markets that Technical Ceramics serve have been showing improved demand during the year. US markets, in particular, have recovered strongly, Asian demand is growing well and Europe, though more subdued, is also showing a positive trend. Across the Technical Ceramics business, strong order intake through the year has resulted in order books building steadily from the trough levels of 2009.

 

Aerospace markets have recovered well from the slowdown seen in mid 2009 with our US metals business, in particular, benefitting from its alignment with this sector.

Demand for consumer electronics has been robust and the take-up of our new products in hard disk drive applications is very encouraging. The medical device market remains soft for the time being, mainly due to destocking in the supply chain, but there are some signs of recovery potential for 2011. In power generation, the continued weakness of the industrial gas turbine market held back our Certech businesses, in both the US and Europe, whilst solar, which started the year slowly, picked up in the second half.

 

 

Thermal Ceramics Business

 

Thermal Ceramics continued to see improving end market demand across all regions in the third quarter of the year. As a result, order books in emerging markets, particularly China and India, have continued to improve and the North America and Europe regions have also seen an increase in activity.

 

The chemical and petroleum sector remains robust with good demand in the Middle East and Latin America. Iron and steel demand has recovered from a very low base, as well as revenues from the automotive industry.

 

 

Morgan Engineered Materials Division

 

Advanced Materials &Technology Business - (formerly Carbon)

 

The Advanced Materials & Technology business has continued to recover across the broad range of its end markets in the third quarter of the year. Of particular note has been the strength of growth in our China business. The cost reduction initiatives started in 2009 and continuing in 2010, combined with our commitment to a low cost strategy, continue to yield benefits in our operating profit levels. We continue to pursue opportunities in the renewable energy sector with growing success in both the wind and solar energy markets.

 

 

NP Aerospace

 

NP Aerospace is expected to deliver 2010 revenues in line with our previously stated expectations of c.£120m. The business continues to pursue a number of domestic and international opportunities with existing and new customers. To support this, we have officially launched NP Aerospace in the US, opening an office in Detroit, and we are actively engaged with potential new customers on current and future US programmes.

 

 

 Molten Metal Systems

 

The strong performance in the Molten Metal Systems business in the first half has continued through the third quarter and we have continued to see increased demand levels in emerging markets.

 

 

Financial position

 

There was no material change in the financial position of the Group during the period. The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end.

 

 

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

Rollo Head/Clare Hunt

Finsbury

020 7251 3801

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBIXBBGGL
Date   Source Headline
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.